Biotech Ascentage Pharma Received Clearance from U.S. FDA to Proceed with Global Registrational Phase III Clinical Trial for Lisaftoclax (APG-2575) in Previously Treated Patients with CLL/SLL August 7, 2023
Biotech Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy August 5, 2023
Biotech PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) August 5, 2023
Biotech Agricultural Biologicals Market To Reach USD 13500 million by 2029, witnessing a CAGR of 7.1% | Valuates Reports August 4, 2023
Biotech Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update August 4, 2023
Biotech Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th August 4, 2023